EX-23.1 4 alt-ex231_10.htm EX-23.1 alt-ex231_10.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

Form

Registration Number

Date Filed

S-8

   333-233273

8/14/2019

S-3

   333-230723

4/4/2019

S-8

   333-230722

4/4/2019

S-8

    333-228623

11/30/2018

S-3

S-8

S-8

S-8

 

333-217034

333-217846

333-214765

333-156371

 

3/30/2017

5/10/2017

11/22/2016

12/19/2008

 

 

of our report dated March 27, 2020, with respect to the consolidated financial statements of Altimmune, Inc., included in this Annual Report (Form 10-K) of Altimmune, Inc. for the year ended December 31, 2019.

 

/s/ Ernst & Young LLP

 

Baltimore, Maryland

March 27, 2020